The Princess Alexandra Hospital NHS Trust Pathology Service Deploys ICE Sample Collection Module

CliniSys GroupThe pathology service at The Princess Alexandra Hospital NHS Trust (PAHT) in Harlow has introduced the CliniSys Integrated Clinical Environment (ICE) sample collection module to improve efficiency and experiences for their patients and staff.

Clinicians at PAHT and local GPs use the module, which has enabled them to remove paper order forms from inpatient wards and the outpatients department.

The clinicians now use the module on iPads to check through patient details and print the labels for the blood tubes that are then sent to the laboratory.

For an extra measure of safety, the system has been set up so that phlebotomists can scan patient hospital wristbands before taking a sample, in a process known as positive patient identification.

Within the outpatients department, where patients do not have a hospital wristband, phlebotomists complete a thorough checklist to confirm that the patient's details are correct.

Nicola Maguire, specialist biomedical scientist at PAHT, said: "We decided to introduce the ICE sample collection module during the COVID-19 pandemic. At the time, there were limited face-to-face GP appointments, which made it difficult to retrieve the paper order forms.

"GPs now order the tests using ICE and patients can book an appointment with the phlebotomist using our online appointment system called Swiftqueue.

"When the patient arrives at their appointment, the phlebotomists can look up and confirm the patient's details and the required blood tests on their iPad.

"The system has improved the process of collecting blood samples, making it more simple and efficient for our teams to use. The system also helps to enhance patient safety and experiences.

"We are planning to extend the system into our emergency department and maternity department.

"A huge thank you to ClinSys for their support with introducing the system, it has made a real difference to our patients and people."

Glyn Hughes, ICE product manager at CliniSys, said: "This is an exemplary piece of work that demonstrates the benefit of being able to think through the testing process from order to sample collection to processing in the lab.

"We are delighted to have been able to support the pathology service at PAHT, in rolling out the ICE sample collection module and integrating it so closely into its processes.

"It's great to hear about the practical efficiency and safety benefits that the trust has achieved, and we look forward to helping other CliniSys customers to realise the same achievements by working in this way."

About CliniSys

CliniSys, headquartered in Chertsey, England and Tucson, Arizona, is the largest provider of laboratory information systems, order entry and result consultation, and public health solutions in disease surveillance and outbreak management across the United Kingdom, Europe, and the United States. For 40 years, successfully specialising in complex and the wide scale delivery of comprehensive laboratory and public health solutions in over 3,000 laboratories across 34 countries using CliniSys solutions.

Our combined cross-discipline expertise provides customers with solutions to support laboratory workflow across clinical, histology, molecular, genetics, including order management, reporting and results delivery. Additionally, we serve laboratories in environmental testing, water quality, agriculture, and toxicology.

Most Popular Now

Herefordshire and Worcestershire Health …

Herefordshire and Worcestershire Health and Care NHS Trust has successfully implemented Alcidion's Miya Precision platform to streamline bed management workflow across seven community hospitals in Worcestershire. The trust delivers community...

With Huge Patient Dataset, AI Accurately…

Scientists have designed a new artificial intelligence (AI) model that emulates randomized clinical trials at determining the treatment options most effective at preventing stroke in people with heart disease. The model...

A Shortcut for Drug Discovery

For most human proteins, there are no small molecules known to bind them chemically (so called "ligands"). Ligands frequently represent important starting points for drug development but this knowledge gap...

New Horizon Europe Funding Boosts Europe…

The European Commission has announced the launch of new Horizon Europe calls, with a substantial funding pool of over €112 million. These calls are aimed primarily at pioneering projects in...

Cleveland Clinic Study Finds AI can Deve…

Cleveland Clinic researchers developed an artficial intelligence (AI) model that can determine the best combination and timeline to use when prescribing drugs to treat a bacterial infection, based solely on...

New AI-Technology Estimates Brain Age Us…

As people age, their brains do, too. But if a brain ages prematurely, there is potential for age-related diseases such as mild-cognitive impairment, dementia, or Parkinson's disease. If "brain age...

Radboud University Medical Center and Ph…

Royal Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, and Radboud University Medical Center have signed a hospital-wide, long-term strategic partnership that delivers the latest patient monitoring...

GPT-4, Google Gemini Fall Short in Breas…

Use of publicly available large language models (LLMs) resulted in changes in breast imaging reports classification that could have a negative effect on patient management, according to a new international...

ChatGPT fails at heart risk assessment

Despite ChatGPT's reported ability to pass medical exams, new research indicates it would be unwise to rely on it for some health assessments, such as whether a patient with chest...

Study Shows ChatGPT Failed when Challeng…

With artificial intelligence (AI) poised to become a fundamental part of clinical research and decision making, many still question the accuracy of ChatGPT, a sophisticated AI language model, to support...

Virtual Reality Shows Promise in Fightin…

A new study published in JMIR Mental Health sheds light on the promising role of virtual reality (VR) in treating major depressive disorder (MDD). Titled "Examining the Efficacy of Extended...

AXREM and Highland Marketing Partner to …

AXREM represents member companies that collectively provide UK hospitals with most of their diagnostic medical imaging technology, and radiotherapy equipment. The association has seen substantial growth in recent years, with membership...